Bridgewater, NJ, United States of America

Yongkui Sun

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2000-2009

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Yongkui Sun in Asymmetric Synthesis

Introduction

Yongkui Sun is a notable inventor based in Bridgewater, NJ (US), recognized for his contributions to the field of asymmetric synthesis. He holds a total of five patents, showcasing his innovative approaches to the preparation of beta amino acid derivatives. His work has significant implications in the synthesis of biologically active molecules.

Latest Patents

Yongkui Sun's latest patents include a process for the preparation of enantiomerically enriched beta amino acid derivatives. This invention focuses on an efficient method for preparing these derivatives with an unprotected amino group. The chiral beta amino acid derivatives produced are essential for the asymmetric synthesis of biologically active molecules. Another significant patent involves the preparation of chiral beta amino acid derivatives through asymmetric hydrogenation. This process utilizes an enantioselective hydrogenation of a prochiral beta amino acrylic acid derivative substrate, employing a transition metal precursor complexed with a chiral ferrocenyl diphosphine ligand.

Career Highlights

Throughout his career, Yongkui Sun has worked with prominent companies such as Merck & Company, Inc. and Solvias AG. His experience in these organizations has contributed to his expertise in the field of chemistry and patent development.

Collaborations

Yongkui Sun has collaborated with notable coworkers, including Thorsten Rosner and Yi Xiao. These partnerships have likely enhanced his research and development efforts in the field of asymmetric synthesis.

Conclusion

Yongkui Sun's innovative work in the preparation of beta amino acid derivatives has made a significant impact in the field of chemistry. His patents reflect a commitment to advancing the synthesis of biologically active molecules, showcasing his role as a leading inventor in this area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…